CCM
ABBV icon

Carderock Capital Management’s AbbVie ABBV Stock Holding History

Carderock Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-700
Closed -$130K – 73
2025
Q2 		$130K Buy
+700
New +$130K 0.03% 84
2023
Q2 		– Sell
-800
Closed -$127K – 59
2023
Q1 		$127K Buy
+800
New +$122K 0.04% 71
2014
Q2 		– Sell
-16,181
Closed -$832K – 96
2014
Q1 		$832K Sell
16,181
-2,840
-15% -$144K 0.42% 66
2013
Q4 		$1M Sell
19,021
-614
-3% -$30.2K 0.53% 60
2013
Q3 		$878K Sell
19,635
-27,921
-59% -$1.24M 0.51% 61
2013
Q2 		$1.97M Buy
+47,556
New +$2.08M 1.16% 38

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carderock Capital Management's ABBV Position: Q3 2025 in Review

Carderock Capital Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 700 shares — an estimated $130K sold.

Carderock Capital Management first reported a position in ABBV in Q2 2013 and held it in 6 quarters. The position peaked at $1.97M in Q2 2013. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Carderock Capital Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Carderock Capital Management sold 700 AbbVie shares in Q3 2025, an estimated $130K.
  • Carderock Capital Management first reported a position in AbbVie in Q2 2013 and held it in 6 quarters.
  • Carderock Capital Management's AbbVie position peaked at $1.97M in Q2 2013.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Carderock Capital Management's 13F filing for Q3 2025, filed 17 Oct 2025.